Company intelligence / Profile preview

Alan Neuromedical Technologies

Spring, Texas, United Statesalanneuromedical.com ↗

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

VECTTOR Therapy, developed by Alan Neuromedical Technologies, is an FDA-cleared device for the symptomatic relief of chronic intractable pain and management of post-surgical or post-traumatic pain. The system uses electrical stimulation delivered via electrodes placed on acupressure points, with automatic adjustment based on body temperature feedback. It is available by prescription throughout the US.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Dynatronics previously licensed exclusive worldwide rights to related technology for treating chronic and acute musculoskeletal conditions.

Beyond the preview

Go deeper on Alan Neuromedical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alan Neuromedical Technologies.

Explore the full profile